Dept. of Medical Oncology at BBCI since its inception has evolved to provide modern and affordable cancer care services to the patients of North-East India.It comprises of dedicated team of doctors specialized in medical oncology, haematological oncology and paediatric oncology.
Dept. of Medical Oncology offers comprehensive and multidisciplinary treatment forvarious malignancies in adults such ashead-neck, breast, lungs, gastrointestinal tract, gynaecological cancers etc. It also delivers comprehensive and specialized services to both childhood cancers,and haematological malignancies (Leukaemia, lymphoma, Multiple myeloma etc), including bone marrow transplant. Dedicated Paediatric oncology services are available for Child hood cancers such as Brain Tumors, Retinoblastoma (Eye cancer), Bone cancer, Wilms Tumor, Neuroblastoma, Blood cancers (Leukaemia and lymphoma) etc.
Various modalities of treatment available at the department are chemotherapy services, immunotherapy, hormone therapy, biological therapy, targeted therapy and stem cell therapy.
The department of Medical Oncology started its operations in BBCI in 1988. The department has grown from a two room OPD service to a complete department with 5 daily OPDs, 36 indoor beds, 23 chemotherapy daycare beds, Pediatric HDU and a SCT unit. The department was first to conduct stem cell transplantation in a public sector hospital in the North-eastern region. A new 5-bedded SCT unit is planned to be commissioned in May, 2023. Formal academic courses were started in 2016 with 2yr TMC fellowship program in Medical Oncology. This program was extremely successful in producing man-power for North-eastern states and capacity building of regional cancer centres. DM in Medical Oncology was started in 2018 with an annual intake of 2 seats. So far, the department has produced 9 confident Medical Oncologists who are currently serving the nation in various capacities.
The department is currently being served by 5 full time faculties offering services for Solid malignancies, pediatric oncology, hematological cancers and stem cell transplantation.
